Watchlist

Watchlist
Aeglea BioTherapeutics, Inc. (AGLE)
Aeglea BioTherapeutics, Inc. (AGLE)
Rubius Therapeutics Proposes Terms For $200 Million IPO
Quick Take Rubius Therapeutics ( RUBY ) intends to raise $200 million from the sale of its common stock in a U.S. IPO, according to an SEC filing . The firm is a very early stage biopharma developing a diverse pipeline of treatments using red blood cells as the primary delivery mechanis…
Aeglea BioTherapeutics, Inc. (AGLE)